Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02382393 · ClinicalTrials.gov registry record · NA

Reliability and Validity of Online Cognitive Assessments

A NA study, sponsored by Lumos Labs.

Completed
Registry status
NA
Development phase
1,152
Enrollment target

NCT02382393: Completed NA study, sponsored by Lumos Labs.

NCT02382393 is a NA study that has completed, run by Lumos Labs. The registered enrollment target is 1,152 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02382393, a NA study, has completed, sponsored by Lumos Labs.

COMPLETED
Registry status
NA
Development phase
1,152 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the concurrent validity (correlation coefficient of scores at 1 time point) between the Brain Performance Test (BPT, Lumos Labs, Inc.) and a validated third party computerized assessment.

Interventions

  • OTHER Brain Performance Test (BPT, Lumos Labs, Inc)
  • OTHER Computerized Assessment

Trial Details

FieldValue
Enrollment Target 1,152 participants
Start Date 2015-03
Est. Completion 2015-11
Phase NA
Lumos Labs

9 total trials

What the finished NCT02382393 record still lists

NCT02382393 is an interventional study that assigns participants to a tested intervention. Its 1,152 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (18% lower).

The record links to 0 conditions, and to 2 interventions - of which Brain Performance Test (BPT, Lumos Labs, Inc) is the first listed.

NCT02382393 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02382393 about?

NCT02382393 is a clinical study titled "Reliability and Validity of Online Cognitive Assessments". The purpose of this study is to evaluate the concurrent validity (correlation coefficient of scores at 1 time point) between the Brain Performance Test (BPT, Lumos Labs, Inc.) and a validated third party computerized assessment.

What is the current status of trial NCT02382393?

This trial is currently completed. It is a NA study. The enrollment target is 1,152 participants. The study started on 2015-03. Estimated completion is 2015-11.

What interventions are being tested in trial NCT02382393?

The interventions under investigation include: Brain Performance Test (BPT, Lumos Labs, Inc) (OTHER), Computerized Assessment (OTHER).

Who is sponsoring clinical trial NCT02382393?

This trial is sponsored by Lumos Labs, which has 9 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02382393's enrollment target sits among peer trials

1,152 92nd of 2000 higher than 1,909 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04474301 · 1,152 participants

    Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

  • NCT05564026 · 1,151 participants

    Molecular Epidemiology of Pediatric Germ Cell Tumors

  • NCT06408181 · 1,150 participants · Phase 3

    APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

  • NCT06528314 · 1,150 participants · Phase 3

    A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02382393, the US trial registry maintained by the National Library of Medicine. NCT02382393 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.